The EPO published patent application EP3571204A2 covering heterocyclic compounds (C07D 487/04, C07D 495/04) with therapeutic applications. The applicants include the Liverpool School of Tropical Medicine, University of Liverpool, and Eisai R&D Management Co., Ltd. The designated states cover all EPO member states (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

This is an informational patent publication rather than a regulatory rule. Pharmaceutical companies developing anti-infective or anti-parasitic drugs should review the patent claims to assess potential freedom-to-operate concerns. No compliance actions or deadlines are associated with this notice.